Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury
- PMID: 29517828
- DOI: 10.1002/stem.2802
Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury
Abstract
Together with residual host neurons, transplanted neural stem cell (NSC)-derived neurons play a critical role in reconstructing disrupted neural circuits after spinal cord injury (SCI). Since a large number of tracts are disrupted and the majority of host neurons die around the lesion site as the damage spreads, minimizing this spreading and preserving the lesion site are important for attaining further improvements in reconstruction. High mobility group box-1 (HMGB1) is a damage-associated molecular pattern protein that triggers sterile inflammation after tissue injury. In the ischemic and injured brain, neutralization of HMGB1 with a specific antibody reportedly stabilizes the blood-brain barrier, suppresses inflammatory cytokine expression, and improves functional recovery. Using a SCI model mouse, we here developed a combinatorial treatment for SCI: administering anti-HMGB1 antibody prior to transplantation of NSCs derived from human induced pluripotent stem cells (hiPSC-NSCs) yielded a dramatic improvement in locomotion recovery after SCI. Even anti-HMGB1 antibody treatment alone alleviated blood-spinal cord barrier disruption and edema formation, and increased the number of neurites from spared axons and the survival of host neurons, resulting in functional recovery. However, this recovery was greatly enhanced by the subsequent hiPSC-NSC transplantation, reaching an extent that has never before been reported. We also found that this improved recovery was directly associated with connections established between surviving host neurons and transplant-derived neurons. Taken together, our results highlight combinatorial treatment with anti-HMGB1 antibody and hiPSC-NSC transplantation as a promising novel therapy for SCI. Stem Cells 2018;36:737-750.
Keywords: Combinatorial treatment; High mobility group box-1; Neural stem cell; Spinal cord injury; Transplantation.
© 2018 The Authors Stem Cells published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
Similar articles
-
Transplantation of neural stem cells preconditioned with high‑mobility group box 1 facilitates functional recovery after spinal cord injury in rats.Mol Med Rep. 2020 Dec;22(6):4725-4733. doi: 10.3892/mmr.2020.11565. Epub 2020 Oct 6. Mol Med Rep. 2020. PMID: 33174002 Free PMC article.
-
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.Stem Cells Transl Med. 2019 Mar;8(3):260-270. doi: 10.1002/sctm.18-0096. Epub 2018 Nov 28. Stem Cells Transl Med. 2019. PMID: 30485733 Free PMC article.
-
hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.Stem Cell Res Ther. 2021 Mar 11;12(1):172. doi: 10.1186/s13287-021-02217-9. Stem Cell Res Ther. 2021. PMID: 33706803 Free PMC article.
-
Neural stem cell therapy aiming at better functional recovery after spinal cord injury.Dev Dyn. 2018 Jan;247(1):75-84. doi: 10.1002/dvdy.24558. Epub 2017 Sep 6. Dev Dyn. 2018. PMID: 28766845 Review.
-
Human stem cell-derived neurons and neural circuitry therapeutics: Next frontier in spinal cord injury repair.Exp Biol Med (Maywood). 2022 Dec;247(23):2142-2151. doi: 10.1177/15353702221114099. Epub 2022 Aug 16. Exp Biol Med (Maywood). 2022. PMID: 35974701 Free PMC article. Review.
Cited by
-
Transplantation of neural stem cells preconditioned with high‑mobility group box 1 facilitates functional recovery after spinal cord injury in rats.Mol Med Rep. 2020 Dec;22(6):4725-4733. doi: 10.3892/mmr.2020.11565. Epub 2020 Oct 6. Mol Med Rep. 2020. PMID: 33174002 Free PMC article.
-
A Preview of Selected Articles.Stem Cells Transl Med. 2018 Nov;7(11):759-761. doi: 10.1002/sctm.18-0209. Epub 2018 Oct 15. Stem Cells Transl Med. 2018. PMID: 30320968 Free PMC article. Review. No abstract available.
-
HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes.Cells. 2020 Mar 6;9(3):643. doi: 10.3390/cells9030643. Cells. 2020. PMID: 32155899 Free PMC article.
-
Click chemistry extracellular vesicle/peptide/chemokine nanocarriers for treating central nervous system injuries.Acta Pharm Sin B. 2023 May;13(5):2202-2218. doi: 10.1016/j.apsb.2022.06.007. Epub 2022 Jun 10. Acta Pharm Sin B. 2023. PMID: 37250158 Free PMC article.
-
Early-life midazolam exposure persistently changes chromatin accessibility to impair adult hippocampal neurogenesis and cognition.Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):e2107596118. doi: 10.1073/pnas.2107596118. Proc Natl Acad Sci U S A. 2021. PMID: 34526402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical